| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/03/2010 | CA2512926C Methods and compositions for inhibition of angiogenesis |
| 07/29/2010 | WO2010085121A2 Novel organic compound, and an organic electronic device comprising the same |
| 07/29/2010 | WO2010084515A2 A process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof |
| 07/29/2010 | WO2010083570A1 Novel metabolic disease therapy |
| 07/29/2010 | WO2010049946A3 Thyroid receptor ligands |
| 07/29/2010 | US20100190999 Process for the preparation of amorphous atorvastatin calcium |
| 07/29/2010 | US20100190822 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) |
| 07/29/2010 | US20100190766 Antibacterial agents |
| 07/29/2010 | US20100190725 Amino acid derivatives |
| 07/29/2010 | US20100190688 Tetrapeptide analogs |
| 07/29/2010 | US20100189645 Metal chelators and methods of their use |
| 07/28/2010 | EP2210877A1 Methods of making pyrrolidones |
| 07/28/2010 | EP2210876A1 Heterocyclic compound |
| 07/28/2010 | EP2210875A1 Methods of making pyrrolidones |
| 07/28/2010 | EP2210874A1 Methods of making pyrrolidones |
| 07/28/2010 | EP2209504A2 Derivatized tertiary amines and uses thereof |
| 07/28/2010 | EP1763511B1 Phenoxyacetic acid derivatives as ppar agonists |
| 07/28/2010 | EP1412329B1 Methods of making pyrrolidones |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN101786979A (+/-)-marinopyrrole A for resisting methicillin-resistant staphylococcus aureus (MRSA) and synthesized derivative thereof |
| 07/28/2010 | CN101786978A 2-lactamine derivative |
| 07/28/2010 | CN101786962A Method for producing amino acid chelate iron |
| 07/28/2010 | CN101080375B Method for cleaning deposits from equipment that have accumulated during a method for recovering NMP by the introduction of hot water and agitation |
| 07/27/2010 | US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 07/27/2010 | US7763723 Polysaccharide and composition from Antrodia camphorata and use thereof |
| 07/27/2010 | US7763649 Treating cardiac arrhythmia and/or cancerous and pre-cancerous cells by administering specific synthetic carotenoid analogs or derivatives either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation |
| 07/27/2010 | US7763644 Such as 1-(1H-imidazol-1-ylmethyl)pyrrolidin-2-one; levetiracetam (SV2 protein family) binding site ligands; anticonvulsant activity |
| 07/27/2010 | US7763602 Drug resistant Mycobacterium tuberculosis |
| 07/22/2010 | WO2010083442A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | WO2010081783A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/22/2010 | WO2010081341A1 The crystal form i of n-n-propyl-3-(4-methylphenyl) -4-(methylsulfonylphenyl)-2,5-dihydropyrrole-2-one and the preparation method thereof |
| 07/22/2010 | WO2010065447A3 A process for the preparation of tert-butyl (r) - 3 -vinylpyrrolidine- i - carboxylate and intermediates therefor |
| 07/22/2010 | US20100184996 Process of amide formation |
| 07/22/2010 | US20100184986 Sulfonamide-based organocatalysts and method for their use |
| 07/22/2010 | US20100184768 Isoprenyl Compounds and Methods Thereof |
| 07/22/2010 | US20100184764 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/22/2010 | US20100184730 Fatty Acid Acylated Salicylates and Their Uses |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183563 Dentinogenesis promoter and dentinogenic pulp-capping material |
| 07/22/2010 | US20100183532 Performance-Boosting UV-Absorbing Compounds |
| 07/22/2010 | CA2747837A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/21/2010 | EP2208772A1 Luminescent-element material and luminescent element |
| 07/21/2010 | EP2208725A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/21/2010 | EP1893573B1 Inhibitors of hcv replication |
| 07/21/2010 | CN1826310B Novel aminobenzophenone compounds |
| 07/21/2010 | CN101784522A proton acceptor iminium/carbocation-type coupling agents |
| 07/20/2010 | US7759499 used for the treatment or prevention of HCV or amelioration the symptoms of hepatitis C infection, by modulating the interaction of an HCV polypeptide with HCV proteases |
| 07/20/2010 | US7759388 Phenylalanine derivatives |
| 07/20/2010 | US7759043 For resist applications; thermostability, storage stability; color filters |
| 07/20/2010 | CA2486399C Calcium receptor modulating agents |
| 07/20/2010 | CA2266908C O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 07/15/2010 | WO2010081014A1 Novel 4-fluoropyrrolidine-2-carbonyl fluoride compounds and their preparative methods |
| 07/15/2010 | WO2010079605A1 Process for producing high-purity 1-benzyl-3-aminopyrrolidine |
| 07/15/2010 | WO2010079413A2 Dipeptidyl peptidase iv inhibitors |
| 07/15/2010 | WO2010051935A3 Substituted amido phenoxybenzamides |
| 07/15/2010 | WO2010001167A3 Preparation of 3-pyrrole substituted 2-indolinone derivatives |
| 07/15/2010 | US20100179331 Furanose derivatives |
| 07/15/2010 | US20100179211 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 07/15/2010 | US20100179210 Novel enantiomerically pure compounds for the treatment of proliferative disorders |
| 07/15/2010 | US20100179119 Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold |
| 07/15/2010 | US20100178710 Mass Labels |
| 07/15/2010 | CA2749301A1 Dipeptidyl peptidase iv inhibitors |
| 07/14/2010 | EP2206712A1 "Alkaloid aminoester derivatives and medicinal composition thereof" |
| 07/14/2010 | EP2206497A1 Polymorphic form of atorvastatin calcium |
| 07/14/2010 | EP2205560A1 Azabicyclo ý3. 1. 0¨hexyl derivatives as modulators of dopamine d3 receptors |
| 07/14/2010 | EP2205559A1 Renin inhibitors |
| 07/14/2010 | EP2205558A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 07/14/2010 | CN1784457B Imide-linked maleimide and polymaleimide compounds |
| 07/14/2010 | CN101778827A Novel microbiocides |
| 07/14/2010 | CN101775011A N-substituted phenyl-3-methylene heterocyclic arene-2,5-dimethylpyrrole compound and application thereof in anti-HIV/AIDS |
| 07/14/2010 | CN101774958A I-type crystallization of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone and manufacturing method thereof |
| 07/14/2010 | CN101108809B 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 07/13/2010 | US7754898 Method of enantioselective nucleophilic addition reaction of enamide to imine and synthesis method of α-amino-γ-keto acid ester |
| 07/13/2010 | US7754897 stereoselective preparation of aminocyclohexyl ether compounds such as trans-(1R,2R)-aminocyclohexyl ether compounds and/or trans-(1S,2S)-aminocyclohexyl ether compounds; useful in treating arrhythmias |
| 07/13/2010 | US7754886 N-acylsulfonamide apoptosis promoters |
| 07/13/2010 | US7754758 chemokine receptor antagonists, such as 1-{3-[3-(4-fluorophenoxy)pyrrolidine-1-yl]propyl}-3-(3-methoxyphenyl)-urea, used as antiinflammatory agents |
| 07/13/2010 | US7754757 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes |
| 07/13/2010 | CA2557536C Amino alcohol compound |
| 07/13/2010 | CA2500888C Isoquinoline compounds and medicinal use thereof |
| 07/13/2010 | CA2352066C Process for the preparation of derivatized polymers |
| 07/13/2010 | CA2304970C Method and reagents for n-alkylating ureides |
| 07/08/2010 | WO2010078294A1 Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid |
| 07/08/2010 | WO2010077836A2 Pyrrolidine compounds which modulate the cb2 receptor |
| 07/08/2010 | WO2010077586A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors |
| 07/08/2010 | WO2010076474A1 Method for preparing activated esters |
| 07/08/2010 | WO2010076034A1 Toluidine sulfonamides and their use as-inhibitors |
| 07/08/2010 | WO2010076033A1 Toluidine sulfonamides and their use |
| 07/08/2010 | WO2010075869A1 Toluidine sulfonamides and their use |
| 07/08/2010 | WO2010045575A3 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders |
| 07/08/2010 | WO2010033593A3 Rosin derived epoxides and curing agents |
| 07/08/2010 | WO2010028051A3 Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors |
| 07/08/2010 | US20100174096 Methods for Production of Optically Active Fluoropyrrolidine Derivatives |
| 07/08/2010 | US20100174090 Methods of preparing primary, secondary and tertiary carbinamine compounds in the presence of ammonia |
| 07/08/2010 | US20100174084 2-Alkoxy-6-alkyl-phenyl-substituted Spirocyclic Tetramic Acid Derivatives |
| 07/08/2010 | US20100174075 Use of nitric oxide-releasing statins in the treatment of pulmonary arterial hypertension |
| 07/08/2010 | US20100173970 C-nitroso-derived nitroxyl donors |
| 07/08/2010 | US20100173969 Therapeutic agent |
| 07/08/2010 | US20100173880 Alkaloid aminoester derivatives and medicinal composition thereof |
| 07/08/2010 | US20100173778 3-Biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 07/08/2010 | US20100173427 Levetiracetam immunoassays |